174 related articles for article (PubMed ID: 16407172)
1. Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa.
Muroi M; Tanamoto K
J Biol Chem; 2006 Mar; 281(9):5484-91. PubMed ID: 16407172
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa.
Walsh C; Gangloff M; Monie T; Smyth T; Wei B; McKinley TJ; Maskell D; Gay N; Bryant C
J Immunol; 2008 Jul; 181(2):1245-54. PubMed ID: 18606678
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
Ohto U; Fukase K; Miyake K; Shimizu T
Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
[TBL] [Abstract][Full Text] [Related]
4. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
[TBL] [Abstract][Full Text] [Related]
5. MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA.
Meng J; Drolet JR; Monks BG; Golenbock DT
J Biol Chem; 2010 Sep; 285(36):27935-43. PubMed ID: 20592019
[TBL] [Abstract][Full Text] [Related]
6. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
[TBL] [Abstract][Full Text] [Related]
7. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
[TBL] [Abstract][Full Text] [Related]
8. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition.
Akashi S; Nagai Y; Ogata H; Oikawa M; Fukase K; Kusumoto S; Kawasaki K; Nishijima M; Hayashi S; Kimoto M; Miyake K
Int Immunol; 2001 Dec; 13(12):1595-9. PubMed ID: 11717200
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
Lien E; Means TK; Heine H; Yoshimura A; Kusumoto S; Fukase K; Fenton MJ; Oikawa M; Qureshi N; Monks B; Finberg RW; Ingalls RR; Golenbock DT
J Clin Invest; 2000 Feb; 105(4):497-504. PubMed ID: 10683379
[TBL] [Abstract][Full Text] [Related]
10. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
mBio; 2012; 3(4):. PubMed ID: 22872782
[TBL] [Abstract][Full Text] [Related]
12. Identification of key residues that confer Rhodobacter sphaeroides LPS activity at horse TLR4/MD-2.
Irvine KL; Gangloff M; Walsh CM; Spring DR; Gay NJ; Bryant CE
PLoS One; 2014; 9(5):e98776. PubMed ID: 24879320
[TBL] [Abstract][Full Text] [Related]
13. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
14. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.
Meng J; Lien E; Golenbock DT
J Biol Chem; 2010 Mar; 285(12):8695-702. PubMed ID: 20018893
[TBL] [Abstract][Full Text] [Related]
15. The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4.
Muroi M; Tanamoto K
Infect Immun; 2002 Nov; 70(11):6043-7. PubMed ID: 12379680
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent Toll-like receptor 4 (TLR4)-oligomerization is directly linked with TLR4-signaling.
Saitoh S; Akashi S; Yamada T; Tanimura N; Matsumoto F; Fukase K; Kusumoto S; Kosugi A; Miyake K
J Endotoxin Res; 2004; 10(4):257-60. PubMed ID: 15373971
[TBL] [Abstract][Full Text] [Related]
17. Exogenous MD-2 confers lipopolysaccharide responsiveness to human corneal epithelial cells with intracellular expression of TLR4 and CD14.
Lang LL; Wang L; Liu L
Inflammation; 2011 Oct; 34(5):371-8. PubMed ID: 20700758
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.
Ohto U; Fukase K; Miyake K; Satow Y
Science; 2007 Jun; 316(5831):1632-4. PubMed ID: 17569869
[TBL] [Abstract][Full Text] [Related]
19. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
[TBL] [Abstract][Full Text] [Related]
20. Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic.
Cighetti R; Ciaramelli C; Sestito SE; Zanoni I; Kubik Ł; Ardá-Freire A; Calabrese V; Granucci F; Jerala R; Martín-Santamaría S; Jiménez-Barbero J; Peri F
Chembiochem; 2014 Jan; 15(2):250-8. PubMed ID: 24339336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
